Unidad de Gestión Clínica Endocrinología y Nutrición. Instituto de Investigación Biomédica de Málaga (IBIMA), Complejo Hospitalario de Málaga (Virgen de la Victoria) Málaga (Spain). CIBER Fisiopatología de la Obesidad y Nutrición (CB06/03), Málaga, Spain.
Epigenomics in Endocrinology and Nutrition Group. Instituto de Investigacion Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS) and CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn), Málaga, Spain.
BMC Cancer. 2019 Jan 21;19(1):93. doi: 10.1186/s12885-018-5226-4.
Visceral adipose tissue (VAT) has been identified as the essential fat depot for pathogenetic theories that associateobesity and colon cancer. LINE-1 hypomethylation has been mostly detected in tumor colon tissue, but less is known about the epigenetic pattern in surrounding tissues. The aim was to analyze for the first time the potential relationship between serum vitamin D, obesity and global methylation (LINE-1) in the visceral adipose tissue (VAT) from patients with and without colorectal cancer.
A total of 55 patients with colorectal cancer and 35 control subjects participated in the study. LINE-1 DNA methylation in VAT was measured by pyrosequencing. Serum 25(OH)D levels were determined by ELISA.
Cancer patients had lower levels of LINE-1 methylation in VAT compared with the control group. In the subjects with colorectal cancer, LINE-1 DNA methylation levels were associated positively with vitamin D levels (r = 0,463; p < 0.001) and negatively with BMI (r = - 0.334, p = 0.01) and HOMA insulin resistance index (r = - 0.348, p = 0.01). Serum vitamin D was the main variable explaining the LINE-1% variance in the cancer group (β = 0.460, p < 0.001). In a multivariate analysis, subjects with higher LINE-1 methylation values had lower risk of developing colorectal cancer (OR = 0.53; IC95% =0.28-0.99) compared with the control group.
We showed for the first time an association between LINE-1 DNA methylation in VAT and vitamin D levels in subjects with colorectal cancer, highlighting the importance of VAT from cancer patients, which could be modified epigenetically compared to healthy subjects.
内脏脂肪组织 (VAT) 已被确定为与肥胖和结肠癌相关的病原体理论的必要脂肪库。LINE-1 低甲基化主要在肿瘤结肠组织中检测到,但周围组织中的表观遗传模式知之甚少。目的是首次分析患有和不患有结直肠癌的患者内脏脂肪组织 (VAT) 中血清维生素 D、肥胖和整体甲基化 (LINE-1) 之间的潜在关系。
共有 55 名结直肠癌患者和 35 名对照者参与了这项研究。通过焦磷酸测序测量 VAT 中的 LINE-1 DNA 甲基化。通过 ELISA 测定血清 25(OH)D 水平。
与对照组相比,癌症患者的 VAT 中 LINE-1 甲基化水平较低。在结直肠癌患者中,LINE-1 DNA 甲基化水平与维生素 D 水平呈正相关 (r=0.463;p<0.001),与 BMI (r=-0.334,p=0.01) 和 HOMA 胰岛素抵抗指数 (r=-0.348,p=0.01) 呈负相关。血清维生素 D 是解释癌症组 LINE-1%变异的主要变量 (β=0.460,p<0.001)。在多变量分析中,与对照组相比,LINE-1 甲基化值较高的患者患结直肠癌的风险较低 (OR=0.53;95%CI=0.28-0.99)。
我们首次显示 VAT 中的 LINE-1 DNA 甲基化与结直肠癌患者的维生素 D 水平之间存在关联,这突出了癌症患者的 VAT 的重要性,与健康受试者相比,它可能在表观遗传上发生改变。